No Data
No Data
Express News | Summary of shareholding changes on March 20.
Express News | Huaren Pharmaceutical: Hongta Innovation plans to reduce its shareholding by no more than 1% of the company's shares.
Express News | Huaren Pharmaceutical: The wholly-owned subsidiary has received the approval notice for the marketing application of Active Pharmaceutical Ingredient for hydrochloride deoxyephedrine.
Huaren Pharmaceutical Pain Drug Selected Under Hebei-led Procurement Program
Express News | Huaren Pharmaceutical: The wholly-owned subsidiary Anhui Hengxing's product Pentazocine Injection was selected for the centralized bulk procurement of Chemical Drugs led by Hebei in the JING-JIN-JI region.
Huaren Pharmaceutical: 2024 Annual Results Forecast